The Indian Pharmaceutical Congress (IPC) is focusing its energies to build confidence among international regulators about the Indian pharma industry.
As more and more global regulators are viewing Indian pharma industry with suspicion and imposing strict regulations on Indian medicine imports to their country, the upcoming Indian Pharmaceutical Congress from 23-25 January 2015 at Hitex in Hyderabad is focusing its energies to clear the air of confusion and apprehensions about the Indian pharma industry and regulations among the among the international regulators and global pharmaceutical fraternity.
According regulatory experts in India, the major reason for the US FDA, EU and other regulatory bodies to impose stringent regulations on Indian manufacturers is because of the pressure from international manufacturers. As more and more block buster drugs are expected to come out of patent regime by 2015, and as Indian manufacturers are well competent enough to grab that opportunity to develop low cost quality generics, the international pharma community fears heavy competition from India and are resorting to malign the image of Indian pharma industry through their regulators. “India is already recognised as a high quality low cost generic manufacturer in the world. By 2015, India is poised to become ‘Pharmacy of the world’ as it has the knowledge, technology, capacity and infrastructure to develop generic drugs of all the leading brands. Our industry will give tough competition to the international players in the international markets, realising this they are spreading false propoganda against Indian industry.
Through IPC we want to tell the world we are equally competent enough in terms of regulations and quality standards. We want to build confidence among the global regulators, international manufacturers and domestic consumers that Indian industry will always keep pace with international standards and strives to bring high quality and affordable drugs not only to its domestic consumers but also to the international markets,” said K. R. Uday Bhaskar, organising committee Chairman for the 66th IPC.
In view of this, the organisers of 66th IPC have come out with a theme ‘India Pharmacy of the world-Role of Indian regulatory and Pharma Industry’. This theme mainly focuses on regulatory aspects, contemporary issues relating to industry and scientific content. “we have designed theme with an objective to bring back industry into IPC’s fold and create a common platform where industry, regulators and academia meet together and build confidence among all stake holders,” said Raja Bhanu, secretary organising committee.
Regulators from across 20 countries are invited and CEOs of all top pharma companies are expected to take part in the international regulators meet and CEOs conclave which will be organised during the three day IPC congress.